| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d137f8e7503ba75f6edf7cbdf54e98c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb141b396e502bfce986c491d722e401 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 |
| filingDate |
2017-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540ecf3a6c19718b14e766ef6d2cd056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d746d31702ff3788ae7595993555488e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4f63c88b3098cd8d57d7b433e71bf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c109f9fe57c10d95bc22494a5ddcace6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b436fe48696495a3158002f85e7dc779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_906fdef322b4b9d53cdfe86cad844558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f693aaf8527c0186e77c6b9c955e4d |
| publicationDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017137954-A2 |
| titleOfInvention |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| abstract |
Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. Aspects include methods and compositions for providing a passive immune response against the bacteria. In certain embodiments, the methods and compositions involve an antibody that binds Coagulase (Coa). Further aspects relate to immunogenic compositions comprising at least one Staphylococcal coagulase R Domain, wherein the R Domain is 80% identical in sequence to a R Domain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018243394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857220-B2 |
| priorityDate |
2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |